The U.S. Food and Drug Administration approved a pill version of Wegovy, making it the first pill of its kind authorized by the regulator. Novo Nordisk described the once-daily oral formulation as a convenient option that would provide the same weight loss as the injectable. Clinical trials showed an average weight loss of 16.6%, with about one-third of roughly 1,300 participants losing 20% or more. The pill is expected to launch in the U.S. in early January 2026. The approval could boost Novo Nordisk's sales after a difficult year and comes amid intense competition from rivals such as Eli Lilly, with Novo Nordisk shares rising nearly 10% in after-hours trading following the announcement.
"The US Food and Drug Administration (FDA) has approved a pill version of the weight-loss drug Wegovy, according to pharmaceutical giant Novo Nordisk. It is the first pill of its kind to receive approval from the regulator, marking a new era for weight-loss drugs. Wegovy's Danish makers Novo Nordisk said the once-daily pill was a "convenient option" to the injectable and would provide the same weight loss as the shot."
"The Wegovy pill showed an average weight loss of 16.6% during Novo Nordisk's trials, the firm said on Monday. A third of around 1,300 participants experienced 20% or greater weight loss in the same trial, it added. The pill is expected to be launched in the US in early January 2026. "Patients will have a convenient, once-daily pill that can help them lose as much weight as the original Wegovy injection," said Mike Doustdar, the firm's chief executive."
Read at www.bbc.com
Unable to calculate read time
Collection
[
|
...
]